{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:10:31Z","timestamp":1777857031760,"version":"3.51.4"},"reference-count":24,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:p>Background: The slow channel syndrome is a rare hereditary disorder caused by a dominant gain-of-function variant in one of the subunits of the acetylcholine receptor at the neuromuscular junction. Patients typically experience axial, limb and particularly extensor finger muscle weakness. Objective: Age at diagnosis is variable and although the long-term prognosis is important for newly diagnosed patients, extensive follow-up studies are rare. We aim to provide answers and perspective for this patient group by presenting an elaborate description of the lifetime follow-up of two slow channel syndrome patients. Methods: We describe 40 years follow-up in two, genetically confirmed cases (CHRNA1; c.866G\u200a&gt;\u200aT p.(Ser289Ile)(legacy Ser269Ile) and CHRNE; c.721C\u200a&gt;\u200aT p.(Leu241Phe)(legacy Leu221Phe) variants). Results: We find that the disease course has a fluctuating pattern and is only mildly progressive. However, hormonal imbalances, (psychological) stress or excessive hot or cold environments are often aggravating factors. Quinidine and fluoxetine are helpful, but ephedrine and salbutamol may also improve symptoms. Conclusion: Slow channel syndrome is mildly progressive with a fluctuating pattern. The observations reported here provide a lifespan perspective and answers to the most pressing questions about prognosis and treatment options for newly diagnosed patients.<\/jats:p>","DOI":"10.3233\/jnd-220798","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T11:39:08Z","timestamp":1650627548000},"page":"525-532","source":"Crossref","is-referenced-by-count":3,"title":["Slow Channel Syndrome Revisited: 40 Years Clinical Follow-Up and Genetic Characterization of Two Cases"],"prefix":"10.1177","volume":"9","author":[{"given":"Helena T.M.","family":"Boon","sequence":"first","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"van Rheenen","family":"Wouter","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Medical Centre Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik-Jan","family":"Kamsteeg","sequence":"additional","affiliation":[{"name":"Department of Genetics, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan B.M.","family":"Kuks","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[{"name":"Institute de Myologie, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"4","key":"10.3233\/JND-220798_ref1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.410010403","article-title":"A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release","volume":"1","author":"Engel","year":"1977","journal-title":"Ann Neurol"},{"key":"10.3233\/JND-220798_ref2","first-page":"8","article-title":"Investigations of 3 cases of a newly recognized familial, congenital myasthenic syndrome","volume":"104","author":"Engel","year":"1979","journal-title":"Trans Am Neurol Assoc"},{"issue":"6","key":"10.3233\/JND-220798_ref3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ana.410110603","article-title":"A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel","volume":"11","author":"Engel","year":"1982","journal-title":"Ann Neurol"},{"issue":"10","key":"10.3233\/JND-220798_ref4","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/humu.22130","article-title":"Congenital myasthenic syndromes: Achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: A study of 680 patients","volume":"33","author":"Abicht","year":"2012","journal-title":"Human Mutation"},{"issue":"3","key":"10.3233\/JND-220798_ref5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10072-018-3645-2","article-title":"Clinical and genetic characterization of an Italian family with slow-channel syndrome","volume":"40","author":"Angelini","year":"2019","journal-title":"Neurological sciences: Official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology"},{"issue":"1","key":"10.3233\/JND-220798_ref6","first-page":"4","article-title":"Decoding pathogenesis of slow-channel congenital myasthenic syndromes using recombinant expression and mice models","volume":"29","author":"Otero-Cruz","year":"2010","journal-title":"P R Health Sci J"},{"issue":"10","key":"10.3233\/JND-220798_ref7","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/acn3.50902","article-title":"Slow-channel myasthenia due to novel mutation in M2 domain of AChR delta subunit","volume":"6","author":"Shen","year":"2019","journal-title":"Annals of clinical and translational neurology"},{"issue":"21","key":"10.3233\/JND-220798_ref8","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.4103\/0366-6999.192780","article-title":"A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family","volume":"129","author":"Tan","year":"2016","journal-title":"Chinese Medical Journal"},{"issue":"2","key":"10.3233\/JND-220798_ref9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1212\/WNL.59.2.162","article-title":"Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes","volume":"59","author":"Croxen","year":"2002","journal-title":"Neurology"},{"issue":"7","key":"10.3233\/JND-220798_ref10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.nmd.2013.04.001","article-title":"Quinine sulfate as a therapeutic option in a patient with slow channel congenital myasthenic syndrome","volume":"23","author":"Peyer","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"15","key":"10.3233\/JND-220798_ref11","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1523\/JNEUROSCI.17-15-05651.1997","article-title":"Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit","volume":"17","author":"Milone","year":"1997","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"3","key":"10.3233\/JND-220798_ref12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1073\/pnas.92.3.758","article-title":"Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit","volume":"92","author":"Ohno","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.3233\/JND-220798_ref13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00415-011-6204-9","article-title":"A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome","volume":"259","author":"Chaouch","year":"2012","journal-title":"J Neurol"},{"issue":"5","key":"10.3233\/JND-220798_ref14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/6.5.767","article-title":"Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome","volume":"6","author":"Croxen","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JND-220798_ref15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/brain\/110.4.1061","article-title":"The slow channel syndrome","volume":"110","author":"Oosterhuis","year":"1987","journal-title":"Two new cases. Brain"},{"issue":"12","key":"10.3233\/JND-220798_ref16","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/humu.22450","article-title":"A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases","volume":"34","author":"Neveling","year":"2013","journal-title":"Hum Mutat"},{"issue":"3","key":"10.3233\/JND-220798_ref17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00415-012-6709-x","article-title":"Pregnancy in congenital myasthenic syndrome","volume":"260","author":"Servais","year":"2013","journal-title":"Journal of Neurology : Official Journal of the European Neurological Society"},{"issue":"3","key":"10.3233\/JND-220798_ref18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1212\/01.wnl.0000344248.36823.b5","article-title":"Voluntary partial retraction of: Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes","volume":"72","author":"Croxen","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.3233\/JND-220798_ref19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.nbd.2011.10.024","article-title":"A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR \u025bL221F mutation","volume":"45","author":"Chevessier","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"Pt 3","key":"10.3233\/JND-220798_ref20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1113\/jphysiol.2002.034173","article-title":"Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits","volume":"547","author":"Hatton","year":"2002","journal-title":"J Physiol"},{"issue":"1-2","key":"10.3233\/JND-220798_ref21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/s0006-8993(96)00894-3","article-title":"Block of the endplate acetylcholine receptor channel by the sympathomimetic agents ephedrine, pseudoephedrine, and albuterol","volume":"740","author":"Milone","year":"1996","journal-title":"Brain Res"},{"key":"10.3233\/JND-220798_ref22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2013.06.012","article-title":"A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment","volume":"248","author":"Webster","year":"2013","journal-title":"Experimental Neurology."},{"issue":"4","key":"10.3233\/JND-220798_ref23","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/mus.25085","article-title":"Late presentations of congenital myasthenic syndromes: How many do we miss?","volume":"54","author":"Garg","year":"2016","journal-title":"Muscle & Nerve"},{"key":"10.3233\/JND-220798_ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0852-4"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-220798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:50:00Z","timestamp":1777506600000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-220798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":24,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jnd-220798","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]}}}